+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ossotide"

Investigation Report on Chinese Ossotide Market, 2018-2022 - Product Thumbnail Image

Investigation Report on Chinese Ossotide Market, 2018-2022

  • Report
  • August 2018
  • 30 Pages
  • China
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Ossotide is a market of musculoskeletal disorder drugs, which are used to treat conditions such as osteoarthritis, rheumatoid arthritis, and other musculoskeletal diseases. These drugs are designed to reduce pain, improve mobility, and reduce inflammation. They can be taken orally, injected, or applied topically. Commonly used drugs in this market include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs). Ossotide drugs are used to treat a wide range of musculoskeletal disorders, including osteoarthritis, rheumatoid arthritis, gout, and ankylosing spondylitis. They are also used to treat other conditions such as bursitis, tendinitis, and fibromyalgia. The Ossotide market is highly competitive, with many companies offering a variety of drugs. Some of the major players in this market include Pfizer, Merck, Novartis, AbbVie, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline. Show Less Read more